Complete genome sequence of Edwardsiella tarda strain GBS0709 isolated from a Japanese patient with the acute motor axonal neuropathy subtype of Guillain–Barré syndrome
Masayuki Imajoh, Masahiro Mori, Takeshi Shimizu, Yume Koizumi, Yuma Kobayashi, Miyu Kawahara, Masanori Daibata

TL;DR
This paper reports the full genome sequence of a bacterial strain linked to a rare nerve disorder in a Japanese patient.
Contribution
The study provides the complete genome sequence of Edwardsiella tarda strain GBS0709 associated with acute motor axonal neuropathy.
Findings
The genome consists of a 3,632,068 bp circular chromosome and a 5,386 bp plasmid.
The guanine and cytosine content of the genome is 57.3%.
Abstract
The complete genome sequence of Edwardsiella tarda strain GBS0709, isolated from an 81-year-old Japanese patient with the acute motor axonal neuropathy subtype of Guillain–Barré syndrome, was determined. It comprised a 3,632,068 bp circular chromosome and a 5,386 bp plasmid. The overall guanine and cytosine content was 57.3%.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Number of contigs | 2 |
| Structure | Circular chromosome and plasmid |
| Number of Miseq reads | 2,556,215 |
| Number of MinION reads [ | 113,995 (13,864) |
| Total length (bp) | 3,637,454 |
| GC content (%) | 57.3 |
| Coverage (×) | 260 |
| 3,632,068 | |
| Number of coding sequences | 3,310 |
| Number of rRNAs | 25 |
| Number of tRNAs | 87 |
| Whole-genome sequence accession no. | |
| DRA accession no. | |
| gANI values of GBS0709 for | |
| NBRC105688 ( | 99.3195 |
| ATCC15947 ( | 99.2589 |
| FDAARGOS_1473 ( | 99.2 |
| ATCC15947 ( | 99.1671 |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPeripheral Neuropathies and Disorders · Clostridium difficile and Clostridium perfringens research · Infectious Diseases and Tuberculosis
ANNOUNCEMENT
Guillain–Barré syndrome (GBS) is a severe acute immune-mediated paralytic neuropathy affecting humans worldwide (1). In 2019, 150,095 cases of GBS were reported globally, with an age-standardized point prevalence of 0.8–6.4 per 100,000 population of which Japan exhibited the highest prevalence (2). The primary infectious agents associated with GBS include Campylobacter jejuni, Mycoplasma pneumoniae, and cytomegalovirus (3). Notably, cases of acute motor axonal neuropathy (AMAN), a subtype of GBS, are often reported in Japan, with C. jejuni infections exclusively eliciting the subtype (4, 5). Strain GBS0709 was isolated on bromothymol blue agar (Eiken Chemical, Japan) by overnight incubation under aerobic conditions at 35℃ from the feces of an 81-year-old Japanese patient with AMAN and identified as Edwardsiella tarda by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (6). Here, we report the complete genome sequence of GBS0709.
Frozen stock of GBS0709 was cultured on brain heart infusion (BHI) agar (BD Difco, USA) overnight at 37°C. A single colony was selected, inoculated into 10 mL of BHI broth, and incubated with shaking overnight at 37°C. Following centrifugation at 16,000 × g for 2 min, genomic DNA was extracted from bacterial pellets using the Wizard HMW DNA Extraction Kit (Promega, USA) following the manufacturer’s instructions and used for Illumina and Nanopore sequencing. Regarding Illumina sequencing, genomic DNA was enzymatically fragmented and prepared to achieve an average size of 330 bp using the QIAseq FX DNA Library Kit (Qiagen, USA) following the manufacturer’s instructions. After adaptor ligation, 20 pM pooled libraries were sequenced on an Illumina MiSeq (MiSeq Reagent Kit v3; 150 cycles, USA), generating 75 bp paired-end reads. Miseq raw reads with Phred-encoded quality scores above 30 were selected for assembly using Trim Galore version 0.6.5 (7). Regarding Nanopore sequencing, genomic DNA was treated with the 1D Ligation Sequencing Kit (SQK-LSK109, Oxford Nanopore Technologies, USA) with Native Barcoding Expansion (EXP-NBD104) without shearing and size selection to avoid fragmentation. After adaptor ligation, the pooled libraries were sequenced on a MinION with an R9.4.1 flow cell using MinKNOW software version 22.05.5. Base calling was performed using Guppy version 4.2.3 in the accurate mode implemented in MinION software. MinION raw reads below a minimum quality score of 8 were discarded using NanoFilt version 2.8.0 (8). Unicycler version 0.4.8 (9) was used for the hybrid assembly of Miseq and MinION reads. Genome error correction, circularization, and rotation were implemented in the Unicycler pipeline. Gene annotation, taxonomy validation, and genomic average nucleotide identity (gANI) calculation were performed using the DDBJ Fast Annotation and Submission Tool version 1.2.0 (10). Default parameters were used for all software unless otherwise specified.
The genomic characteristics of GBS0709 are summarized in Table 1?. GBS0709 was almost identical to four E. tarda strains, with gANI values exceeding 99.1. Although E. tarda infection is a rare cause of bacterial gastroenteritis, wound infections, and bacteremia in humans (11, 12), the genome data of GBS0709 can help to increase our understanding of the virulence of E. tarda.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Willison HJ, Jacobs BC, van Doorn PA. 2016. Guillain-Barré syndrome. Lancet 388:717–727. doi:10.1016/S 0140-6736(16)00339-126948435 · doi ↗ · pubmed ↗
- 2Bragazzi NL, Kolahi AA, Nejadghaderi SA, Lochner P, Brigo F, Naldi A, Lanteri P, Garbarino S, Sullman MJM, Dai H, Wu J, Kong JD, Jahrami H, Sohrabi MR, Safiri S. 2021. Global, regional, and national burden of Guillain-Barré syndrome and its underlying causes from 1990 to 2019. J Neuroinflamm 18:264. doi:10.1186/s 12974-021-02319-4PMC 858112834763713 · doi ↗ · pubmed ↗
- 3Finsterer J. 2022. Triggers of Guillain-Barré Syndrome: Campylobacter jejuni predominates. Int J Mol Sci 23:14222. doi:10.3390/ijms 23221422236430700 PMC 9696744 · doi ↗ · pubmed ↗
- 4Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. 2000. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48:624–631.11026446 · pubmed ↗
- 5Khan SA, Das PR, Nahar Z, Dewan SMR. 2024. An updated review on Guillain-Barré syndrome: challenges in infection prevention and control in low- and middle-income countries. SAGE Open Med 12:20503121241239538. doi:10.1177/2050312124123953838533198 PMC 10964449 · doi ↗ · pubmed ↗
- 6Singhal N, Kumar M, Kanaujia PK, Virdi JS. 2015. MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol 6:791. doi:10.3389/fmicb.2015.0079126300860 PMC 4525378 · doi ↗ · pubmed ↗
- 7Krueger F. 2015. Trim Galore: a wrapper tool around cutadapt and Fast QC to consistently apply quality and adapter trimming to Fast Q files. Available from: https://www.bioinformatics.babraham.ac.uk/projects/trim_galore
- 8De Coster W, D’Hert S, Schultz DT, Cruts M, Van Broeckhoven C. 2018. Nano Pack: visualizing and processing long-read sequencing data. Bioinformatics 34:2666–2669. doi:10.1093/bioinformatics/bty 14929547981 PMC 6061794 · doi ↗ · pubmed ↗
